CP Reports
CP Insight
Current Agreements
CP Knowledge Centre
CP Consulting

Updated report

Provides comprehensive understanding and unprecedented access to the oncology/cancer partnering deals and agreements entered into by the worlds leading healthcare companies. More

 

Featured partnering deals

Novo Nordisk and Xencor seeking biologic drug candidates using XmAb technologies

December 18, 2014 : big pharma, Novo Nordisk, partnering

Xencor has entered into a collaboration and licensing agreement with Novo Nordisk to jointly discover novel biologic drug candidates for an undisclosed target by combining multiple Xencor XmAb technologies more »

Bayer and X-Chem in cardiovascular drug discovery program pact

December 18, 2014 : Bayer, big pharma, partnering

X-Chem has licensed a second drug discovery program to Bayer Pharma pursuant to the multi-target collaboration the companies established in July 2012 more »

 More partnering deals | all deals at Deal Monitor


Featured M&A deals

Merck acquires OncoEthix, gains OTX015

December 18, 2014 : big pharma, M&A, Merck

Merck has acquired OncoEthix more »

Philips acquires Volcano for $1.2 billion

December 18, 2014 : diagnostics, M&A, medical device

Royal Philips and Volcano have entered into a definitive merger agreement. Pursuant to the agreement, Philips will commence a tender offer to acquire all of the issued and outstanding shares of Volcano more »

 More M&A deals | all deals at Deal Monitor

Featured financing deals

Annexon pulls in $34 million series A

December 16, 2014 : financings, pharma

Annexon Bioscience has closed a $34 million Series A-1 to support the development of its lead candidate, ANX005, for the treatment of neurodegenerative and autoimmune disorders more »

Insightec gains $59 million series D financing

December 16, 2014 : financing, medical device

INSIGHTEC closed on a $59 Million Series D financing led by major institutional investors in the United States and Asia more »

 More financing deals | all deals at Deal Monitor

Latest Dealtalk

Biotech rumor mill : Helix BioPharma in the spotlight

December 8, 2014 : big pharma, dealtalk, M&A

Biotech rumor mill: Helix BioPharma Corp. announced Friday that it has begun “a comprehensive exploration of growth opportunities,” code that most of the biotech market has taken to mean the company has a shopping list of potential acquisitions and will be buying snap-on targets soon. more »

Bayer hungry for pharma deals to expand business

October 31, 2014 : Bayer, big pharma, dealtalk, pharma deals

Big pharma company Bayer , is going hunting for pharma deals again, with its chief executive expected to tell media outlets  that it is looking for further takeover pharma deals.  more »

 More dealtalk

CP Scorecard

NEW Top life science deals of 2014 revealed using our CP Scorecard tool.

Partnering | M&A | Financing |
Completed IPOs

Featured reports

Manufacturing & Supply Partnering Terms and Agreements

Publication date: December 2014

Cancer Vaccine Partnering Terms and Agreements

Publication date: December 2014

Asset Purchase Partnering Terms & Agreements

Publication date: December 2014

Royalty Financing Partnering Terms and Agreements

Publication date: December 2014

Cancer Diagnostics Partnering Terms and Agreements

Publication date: December 2014

Gene Therapy Partnering Terms and Agreements

Publication date: December 2014

Biomarker Partnering Terms and Agreements

Publication date: November 2014

Companion Diagnostics Partnering Terms and Agreements

Publication date: November 2014

Personalized Medicine Partnering Terms and Agreements

Publication date: November 2014

Pharmacogenomics Partnering Terms and Agreements

Publication date: November 2014

Option and Evaluation Partnering Terms and Agreements

Publication date: November 2014

View all reports

Print Friendly
cabannerad300x150new4gif
RSS Feed Linked In Twitter

Latest Tweets

cpbannerad300x150new2gif
biovariabanner300x150gif
e57300x150animgif